Bayesian Capital Management’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,467
Closed -$234K 735
2024
Q4
$234K Buy
+5,467
New +$180K 0.03% 538
2020
Q2
Sell
-16,426
Closed -$219K 608
2020
Q1
$219K Buy
+16,426
New +$554K 0.05% 562
2019
Q4
Sell
-14,200
Closed -$568K 657
2019
Q3
$568K Buy
+14,200
New +$548K 0.11% 249
2017
Q2
Sell
-6,233
Closed -$346K 493
2017
Q1
$346K Sell
6,233
-1,300
-17% -$77.5K 0.16% 230
2016
Q4
$468K Buy
+7,533
New +$460K 0.12% 325
2016
Q3
Sell
-7,942
Closed -$511K 407
2016
Q2
$511K Buy
+7,942
New +$525K 0.31% 112

Other funds holding GCO

Bayesian Capital Management's GCO Position: Q1 2025 in Review

Bayesian Capital Management sold out of Genesco (GCO) in Q1 2025, closing a stake of 5,467 shares — an estimated $234K sold.

Bayesian Capital Management first reported a position in GCO in Q2 2016 and held it in 6 quarters. The position peaked at $568K in Q3 2019. 119 funds tracked by Wall St. Rank hold GCO as of Q1 2025.

  • Bayesian Capital Management reported no remaining Genesco position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 5,467 Genesco shares in Q1 2025, an estimated $234K.
  • Bayesian Capital Management first reported a position in Genesco in Q2 2016 and held it in 6 quarters.
  • Bayesian Capital Management's Genesco position peaked at $568K in Q3 2019.
  • 119 funds tracked by Wall St. Rank held Genesco as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.